Abstract
The role of the TSPO in metabolism of human osteoblasts is unknown. We hypothesized that human osteoblast metabolism may be modulated by the TSPO. Therefore we evaluated the presence of TSPO in human osteoblast-like cells and the effect of its synthetic ligand PK 11195 on these cells. The presence of TSPO was determined by [3H]PK 11195 binding using Scatchard analysis: Bmax 7682 fmol/mg, Kd 9.24 nM. PK 11195 did not affect significantly cell proliferation, cell death, cellular viability, maturation, [18F]-FDG incorporation and hexokinase 2 gene expression or protein levels. PK 11195 exerted a suppressive effect on VDAC1 and caused an increase in TSPO gene expression or protein levels. In parallel there was an increase in mitochondrial mass, mitochondrial ATP content and a reduction in ΔΨm collapse. Thus, it appears that PK11195 (10−5 M) stimulates mitochondrial activity in human osteoblast-like cells without affecting glycolytic activity and cell death.
Similar content being viewed by others
References
Avital A, Richter-Levin G, Leschiner S, Spanier I, Veenman L, Weizman A, Gavish M (2001) Neuropsychopharmacology 25:669–678
Award M, Gavish M (1993) J Neurochem 49:1407–1414
Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Nat Cell Biol 9:550–555
Bar-Ami S, Fares F, Gavish M (1991) Mol Cell Endocrinol 82:285–291
Bar-Ami S, Bendel N, Leschiner S, Levin E, Veenman L, Gavish M (2006) Biochem Pharmacol 71:472–478
Bessey OA, Lowry OH, Brock MJ (1946) A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164:321–329
Bortner CD, Oldenburg NB, Cidlowski JA (1995) Trends Cell Biol 5(1):21–26
Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptor and mitochondrial function. Neurochem Int 40:475–486
Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) Biochem Biophys Res Commun 197:40–45
Fares F, Gavish M (1986) Characterization of peripheral benzodiazepine binding sites in human term placenta. Biochem Pharmacol 35:227–230
Galluzzi L, Kroemer G (2007) Nat Cell Biol 9:487–489
Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A (1999) Pharmacol Rev 51:629–649
Gay RB, Bowers GN Jr (1968) Clin Chem 14:740–753
Gundle R, Stewart K, Screen J, Beresford JN (1998) In: Beresford N, Owen ME (eds) Marrow stromal cell culture. Cambridge University Press, Cambridge, pp 43–66
Kroemer G, Reed JC (2000) Nat Med 6:513–519
Krueger KE, Papadopoulos V (1992) Annu Rev Pharmacol Toxicol 32:211–237
Kugler W, Veenman L, Shandalov Y, Leschiner S, Spanier I, Lakomek M, Gavish M (2008) Cell Oncol 30:435–450
Lemasters JJ, Holmuhamedov E (2006) Biochim Biophys Acta 1762:181–190
McEnery MW, Dawson TM, Verma A, Gurley D, Colombini M, Snyder SH (1993) J Biol Chem 268(31):23289–23296
Oubrahim H, Stadtman ER, Chock BP (2001) PNAS 98:9505–9510
Papadopoulos V (1993) Endocr Rev 14:222–241
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapěre JJ, Lindermann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gvish M (2006) Trends Pharmacol Sci 27:402–409
Pastorino JG, Hoek JB (2008) J Bioenerg Biomembr 40:171–182
Rosenberg N, Bettman L, Rosenberg O, Soudry M, Gavish M, Bar-Shalom R (2007) Cytotechnology 54:1–4
Rosenberg N, Soudry M, Rosenberg O, Blumenfeld I, Blumenfeld Z (2010) Exp Clin Endocrinol Diabetes 118(10):708–712
Salvioli S, Dobrucki J, Moretti L, Troiano L, Fernandez MG, Pinti M, Pedrazzi J, Franceschi C, Cossarizza A (2000) Cytometry 40:189–197
Santidrián AF, Cosialls AM, Coll-Mulet L, Iglesias-Serret D, de Frias M, González-Gironès DM, Campàs C, Domingo A, Pons G, Gil J (2007) Haematologica 92:1631–1638
Shoukrun R, Veenman L, Shandalov Y, Leschiner S, Spanier I, Karry R, Katz Y, Weisinger G, Weizman A, Gavish M (2008) Pharmacogenet Genomics 18:977–988
Veenman L, Leschner S, Weisinger G, Weizman A, Gavish M (2002) J Neurochem 80:917–927
Veenman L, Papadopoulos V, Gavish M (2007) Curr Pharm Des 13:1–21
Veenman L, Shandalov Y, Gavish M (2008) J Bioenerg Biomembr 40:199–205
Veenman L, Alten J, Linnemannstons K, Shandalov Y, Zeno S, Lakomek M, Gavish M, Kugler W (2010) Apoptosis 15:753–768
Weissman BA, Elson HF, Kaplan D, Newman AH (1990) Eur J Pharmacol 187:369–375
Weizman R, Gavish M (1993) Clin Neuropharmacol 16:273–278
Yamanouchi K, Satomura K, Gotoh Y, Kitaoka E, Tobiume S, Kume K, Nagayama M (2001) J Bone Miner Res 16:857–867
Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M (2009) Biochemistry 48:4652–4661
Author information
Authors and Affiliations
Corresponding author
Additional information
Nahum Rosenberg and Orit Rosenberg had equal contribution
Rights and permissions
About this article
Cite this article
Rosenberg, N., Rosenberg, O., Weizman, A. et al. In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells. J Bioenerg Biomembr 43, 739–746 (2011). https://doi.org/10.1007/s10863-011-9388-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-011-9388-x